Aubra Eq
Product Images NDC 53002-2692

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aubra Eq (NDC 53002-2692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022692)

Aubra EQ 0.1/0.02 mg tablets packaging label for a 28-day regimen, displaying directions to take one tablet daily as directed. The label includes the 1 Month Pack designation, prescription only indication, and space for patient and clinic information. The labeler is RPK Pharmaceuticals, Inc., and the NDC is 53002-2692.*

FDA Label Image

Figure I: Mean (se) Levonorgestrel And Ethinyl Estradiol Serum Concentrations In 22 Subjects Receiving Levonorgestrel And Ethinyl Estradiol (100 Mcg Levonorgestrel And 20 Mcg Ethinyl Estradiol) (Levo Ethi Fig1)

Pharmacokinetic curves showing Levonorgestrel and Ethinyl Estradiol concentration (ng/mL) over time (hours) on Days 1, 6, and 21. The graphs plot drug concentration on the vertical axis against time on the horizontal axis, illustrating changes in plasma levels for each active ingredient across the three time points.*

FDA Label Image

Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral-contraceptive Use (Levo Ethi Fig2)

Bar graph showing circulatory disease mortality rates per 100,000 woman years by age groups (15-24, 25-34, 35-44, 45-) differentiated by smoking status and oral-contraceptive use. Four categories are compared: ever-users (nonsmokers), controls (nonsmokers), ever-users (smokers), and controls (smokers), with mortality rates increasing with age and highest in ever-users who smoke at age 45 and older.*

FDA Label Image

Levo-ethi-fig3 (Levo Ethi Fig3)

A forest plot showing effect estimates (odds ratios/risk ratios) with 95% confidence intervals for several contraceptive-related studies, including NICHD, French E3N, Shanghai Women’s Health, The Nurses’ Health II, Oxford Family Planning Association, and Danish Sex Hormone Register studies. The effect estimates range approximately from 0.9 to 1.3.*

FDA Label Image

Levo-ethi-fig4 (Levo Ethi Fig4)

An illustrated medication blister pack diagram for Aubra EQ (Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg). It shows four rows of tablets arranged by week, with arrows indicating the sequence to take them Sunday through Saturday. The first three rows contain white to off-white tablets, while the fourth row contains green tablets labeled as inactive.*

FDA Label Image

Levo-ethi-fig5 (Levo Ethi Fig5)

Illustration showing how to use day labels on an Aubra EQ tablet blister pack. It demonstrates peeling and placing the correct day label strip on the top of the blister to track daily tablet use. The example shows four rows of tablets, with the first three rows white to off-white and the fourth row green, labeled Aubra EQ (Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg). Arrows guide the sequence to follow for taking tablets.*

FDA Label Image

Levo-ethi-fig6 (Levo Ethi Fig6)

An instructional diagram showing a weekly tablet-taking schedule for Aubra EQ (Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg). It displays four rows representing weeks, with the first three weeks containing white to off-white circles for active tablets and the fourth week having green circles for inactive tablets. Arrows indicate the order to take the tablets, starting from Sunday and following through Saturday for each week.*

FDA Label Image

Levo-ethi-fig7 (Levo Ethi Fig7)

Illustration showing how to select the correct day label and apply it to an Aubra EQ blister pack for oral contraceptive tablets. The diagram demonstrates peeling and placing a day strip labeled with days of the week on the blister and indicates tablet colors and order, with specific mention of green tablets corresponding to four tablets in week four marked as inactive.*

FDA Label Image

Chemical Structure (Levo Ethi Str)

Chemical structures of Levonorgestrel and Ethinyl Estradiol. The diagram shows molecular structures with labeled atoms and bonds for these two active ingredients commonly used in hormonal contraceptives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.